Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Thermo Fisher Scientific Inc (TMO)

Healthcare Diagnostics & Research
574.30 $
-0.4% vs. previous close
Closing price · As of: 31. Jul 2026

Thermo Fisher Scientific Inc (TMO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 110,343 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow
Annual Quarterly

All figures in millions of USD.

Balance Sheet TMO
Tick rows to compare them in a chart (up to 4) 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
42,852 40,834 45,908 56,669 56,232 58,381 69,052 95,123 97,154 98,726 97,321 110,343
6,540 5,741 7,021 9,421 10,625 11,893 21,957 20,113 25,229 24,589 22,137 28,707
1,344 452 786 1,335 2,103 2,399 10,325 4,477 8,524 8,083 4,019 9,857
1,344 452 786 1,335 2,103 2,399 10,325 4,477 8,524 8,083 5,580 10,110
2,474 2,545 3,049 3,879 4,595 4,952 6,472 8,945 9,427 9,664 9,626 10,566
1,860 1,992 2,213 2,971 3,005 3,370 4,029 5,051 5,634 5,088 4,978 5,425
2,427 2,449 2,578 4,047 4,165 4,749 5,912 8,333 9,280 11,004 10,795 10,565
18,843 18,828 21,328 25,290 25,347 25,714 26,041 41,924 41,196 44,020 45,853 49,362
14,110 12,758 13,969 16,684 14,978 14,014 12,685 20,146 17,478 16,670 15,533 15,838
22,304 19,484 24,368 31,256 28,646 28,706 34,535 54,146 53,006 51,884 47,650 56,807
5,350 4,146 4,866 7,048 6,147 6,197 10,304 13,436 17,010 14,012 13,332 15,189
2,212 1,052 2,097 2,135 1,271 843 2,812 2,803 5,851 3,872 2,475 3,808
821 822 926 1,428 1,615 1,920 2,175 2,867 3,381 2,872 3,079 3,622
12,352 11,420 15,372 18,873 17,719 17,076 19,107 32,333 28,909 31,308 29,061 35,852
20,548 21,350 21,539 25,413 27,586 29,675 34,507 40,793 43,978 46,735 49,584 53,407
10,407 12,142 13,927 15,914 18,696 22,092 28,116 35,431 41,910 47,364 53,102 59,156
402 402 397 398 406 403 399 397 394 388 383 377

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?